Ir al contenido principal
  • Iniciar sesión
    Bienvenido.
    Mi cuenta
    Cierre de sesión

STATE STREET CORP (STT) Previsión de existencias 2025 - Predicción y análisis del precio de la IA

STATE STREET CORP (STT) Previsión del precio de las acciones de AI y análisis de inversiones

STATE STREET CORP Gráfico de cotizaciones y análisis técnico

Loading STATE STREET CORP gráfico interactivo de cotizaciones y análisis técnico...

STATE STREET CORP (STT) - Análisis exhaustivo de valores e investigación de inversiones

Deep dive into STATE STREET CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about STATE STREET CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

Para STATE STREET CORP: STATE STREET CORP operates in the Finance sector, positioning it as a large-cap market leader.

STATE STREET CORP (Símbolo bursátil: STT) es una empresa líder en el sector Finance. que opera específicamente en la industria State Commercial Banks..

La organización emplea a unos 42301 profesionales en todo el mundo .

La empresa se ha consolidado como un gran líder del mercado con un importante respaldo institucional.

Understanding Financial Performance

Qué significan estas métricas: Key financial indicators showing STATE STREET CORP's revenue scale, profitability, market value, and shareholder returns.

Cómo leerlos: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Para STATE STREET CORP: With $13403M in annual revenue and 16,7% net margin, the company demonstrates exceptional profitability.

Ingresos anuales: $13403 millones generar un 16,7% margen de beneficio neto .

Capitalización bursátil: $32300 millones - Clasificado como valores de gran capitalización con estabilidad institucional.

Rentabilidad de los fondos propios (ROE): 11,3% - Por encima de la media eficiencia de la rentabilidad para el accionista, lo que indica áreas de mejora operativa.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for STATE STREET CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

Para STATE STREET CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Desbloquea las predicciones de IA Premium para acceder a nuestras previsiones avanzadas de aprendizaje automático para la acción STATE STREET CORP, incluidos objetivos de precio a 7, 30 y 90 días con intervalos de confianza y evaluaciones de riesgo.

Understanding Market Position

What this analysis covers: STATE STREET CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

Para STATE STREET CORP: Strong free cash flow generation demonstrates solid operational efficiency.

STATE STREET CORP compite estratégicamente en el altamente dinámico State Commercial Banks mercado, posicionarse como líder dominante del mercado de gran capitalización con importantes fosos competitivos y la confianza de los inversores institucionales .

La empresa demuestra una sólida eficiencia operativa a través de una fuerte generación de flujo de caja libre de $821 millones anualescomplementado por un impresionante crecimiento interanual del flujo de caja..

STATE STREET CORP (STT) Análisis fundamental y datos sobre operaciones con información privilegiada (Informes financieros trimestrales)

Datos financieros trimestrales completos, tendencias de beneficios, transacciones con información privilegiada y participaciones institucionales de STATE STREET CORP análisis de valores.

Cargando STATE STREET CORP análisis fundamental exhaustivo y datos de información privilegiada...

Profundice en la salud financiera, las métricas de valoración y la eficiencia operativa de STATE STREET CORP para tomar decisiones de inversión informadas.

Comprender las métricas de valoración

Qué significan estas métricas: Las métricas de valoración ayudan a determinar si las acciones STATE STREET CORP tienen un precio justo en comparación con sus beneficios, activos y posición en el mercado.

Cómo leerlos: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

Para STATE STREET CORP: Con un PER de 11,33, el mercado ve las acciones potencialmente infravaloradas.

P/E Ratio 11,33x
P/B Ratio 1,18x
Market Cap $32300M
Dividend Yield 2,74%
EPS $9,04
Valor contable/acción $93,63
Ingresos/Acciones $45,96
FCF/Acción $1,74
Entender las métricas de rentabilidad

Qué significan estas métricas: Estos ratios miden la eficacia con la que STATE STREET CORP convierte los ingresos en beneficios y genera rentabilidad para los accionistas.

Cómo leerlos: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Para STATE STREET CORP: Un ROE de 11,3% muestra bien creación de valor para el accionista.

ROE 11,3%
ROA 0,8%
Net Margin 16,7%
EBT Margin 29,8%
Tax Rate 15,8%
Entender las métricas de salud financiera

Qué significan estas métricas: Estos ratios evalúan la capacidad de STATE STREET CORP para hacer frente a las obligaciones a corto plazo y gestionar eficazmente los niveles de endeudamiento.

Cómo leerlos: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

Para STATE STREET CORP:

D/E Ratio 0,57x
Financial Leverage 13,29x
Entender las métricas del flujo de caja

Qué significan estas métricas: Las métricas de flujo de caja revelan la capacidad de STATE STREET CORP para generar efectivo a partir de operaciones y financiar iniciativas de crecimiento.

Cómo leerlos: El flujo de caja operativo positivo es crucial. El flujo de caja libre muestra el dinero disponible para dividendos, recompras o inversiones.

Para STATE STREET CORP: Flujo de caja libre de $821M proporciona flexibilidad para el rendimiento de los accionistas y las inversiones de crecimiento.

Operating Cash Flow $1608M
Free Cash Flow $821M
Capital Spending $-787M
OCF Growth YoY -37,9%
FCF Growth YoY -40,1%
FCF/Sales 7,4%
CapEx/Sales 7,1%
Entender las métricas de eficiencia operativa

Qué significan estas métricas: Estos ratios miden la eficacia con la que STATE STREET CORP utiliza sus activos y gestiona el capital circulante.

Cómo leerlos: Unos índices de rotación más elevados indican una utilización eficaz de los activos. Los periodos de cobro más cortos muestran una gestión eficaz del crédito.

Para STATE STREET CORP: Una rotación de activos de 0,03x sugiere un margen de mejora en utilización de activos.

Asset Turnover 0,03x
Fixed Assets Turnover 4,0x
Comprender los datos de los estados financieros

Qué significan estas métricas: Cifras clave de la cuenta de resultados y el balance de STATE STREET CORP que muestran los resultados financieros absolutos.

Cómo leerlos: Los ingresos muestran la escala empresarial, mientras que los márgenes indican la rentabilidad. Las partidas del balance revelan la estructura financiera.

Para STATE STREET CORP: Con unos ingresos anuales de 13403M, STATE STREET CORP opera a gran escala.

Cuenta de resultados ($ Millones)
Ingresos totales $13403M
Gastos de venta, generales y administrativos $42M
Hechos destacados del balance (% Of Assets)
Cash & Short-term Investments 37%
Total Liabilities 92%
Short-term Debt 0%
Accounts Receivable 2%
Información sobre dividendos y accionistas
Dividends Per Share $3,04
Payout Ratio 0,3%
Shares Outstanding 292M
Métricas de crecimiento (interanual)
EPS Growth 6,5%

Última STATE STREET CORP Noticias y análisis bursátiles

Noticias de última hora, informes de analistas y actualizaciones del mercado que afectan a la cotización de STATE STREET CORP (STT) y a las perspectivas de inversión.

, fuente: The New York Times

BlackRock, JPMorgan Chase and State Street are quitting or scaling back their ties to an influential global investment coalition. By Andrew Ross Sorkin, Ravi Mattu, Bernhard Warner, Sarah Kessler, ...

STATE STREET CORP Competidores y análisis de pares - Finance Sector

Análisis comparativo de STATE STREET CORP frente a sus homólogos y competidores del sector Finance, con previsiones basadas en IA y métricas financieras clave.

Empresa Código bursátil Previsión de IA a 90 días Capitalización bursátil (M USD) Ratio PER Ratio P/B
ABCB Unlock Forecast - 30 Days FREE Trial $5094M 13,0x 1,3x
ACNB Unlock Forecast - 30 Days FREE Trial $471M 18,7x 1,2x
ALLY Unlock Forecast - 30 Days FREE Trial $12250M 15,3x 0,9x
AMAL Unlock Forecast - 30 Days FREE Trial $1010M 10,8x 1,3x
ASB Unlock Forecast - 30 Days FREE Trial $4376M 31,4x 0,9x
ASBA Unlock Forecast - 30 Days FREE Trial $4154M 29,8x 0,9x
ASB-PE Unlock Forecast - 30 Days FREE Trial $3661M 26,3x 0,8x
ASB-PF Unlock Forecast - 30 Days FREE Trial $3552M 25,5x 0,7x
AUB Unlock Forecast - 30 Days FREE Trial $4989M 24,5x 1,0x
AUBN Unlock Forecast - 30 Days FREE Trial $77M 12,6x 1,1x
AUB-PA Unlock Forecast - 30 Days FREE Trial $3541M 17,4x 0,7x
BAFN Unlock Forecast - 30 Days FREE Trial $37M 4,0x 0,3x
BANR Unlock Forecast - 30 Days FREE Trial $2329M 12,8x 1,3x
BCML Unlock Forecast - 30 Days FREE Trial $331M 13,7x 1,0x
BFST Unlock Forecast - 30 Days FREE Trial $745M 9,7x 0,9x
BHB Unlock Forecast - 30 Days FREE Trial $493M 12,5x 1,1x
BK Unlock Forecast - 30 Days FREE Trial $76287M 15,3x 1,7x
BK-PK Unlock Forecast - 30 Days FREE Trial $18624M 3,7x 0,4x
BKSC Unlock Forecast - 30 Days FREE Trial $87M 13,4x 2,1x
BMRC Unlock Forecast - 30 Days FREE Trial $400M 57,8x 0,9x
BMTX Unlock Forecast - 30 Days FREE Trial $58M -4,5x 2,7x
BOH Unlock Forecast - 30 Days FREE Trial $2722M 15,9x 1,6x
BOH-PA Unlock Forecast - 30 Days FREE Trial $699M 4,1x 0,4x
BOH-PB Unlock Forecast - 30 Days FREE Trial $1070M 6,3x 0,6x
BOTJ Unlock Forecast - 30 Days FREE Trial $70M 9,8x 1,0x
BPOP Unlock Forecast - 30 Days FREE Trial $8583M 11,9x 1,4x
BPOPM Unlock Forecast - 30 Days FREE Trial $1734M 2,4x 0,3x
BPOPO Unlock Forecast - 30 Days FREE Trial $1712M 2,4x 0,3x
BPRN Unlock Forecast - 30 Days FREE Trial $225M 32,9x 0,9x
BRBS Unlock Forecast - 30 Days FREE Trial $358M -1,3x 1,0x
BSRR Unlock Forecast - 30 Days FREE Trial $417M 10,3x 1,2x
BSVN Unlock Forecast - 30 Days FREE Trial $466M 10,5x 2,0x
BUSE Unlock Forecast - 30 Days FREE Trial $2194M 13,3x 1,0x
BWB Unlock Forecast - 30 Days FREE Trial $451M 11,9x 1,0x
BWBBP Unlock Forecast - 30 Days FREE Trial $549M 14,5x 1,2x
BWFG Unlock Forecast - 30 Days FREE Trial $339M 16,3x 1,2x
BY Unlock Forecast - 30 Days FREE Trial $1321M 11,1x 1,1x
CATY Unlock Forecast - 30 Days FREE Trial $3470M 11,8x 1,2x
CBAN Unlock Forecast - 30 Days FREE Trial $299M 10,8x 1,0x
CBFV Unlock Forecast - 30 Days FREE Trial $177M 15,2x 1,2x
CBSH Unlock Forecast - 30 Days FREE Trial $7555M 15,5x 3,1x
CCB Unlock Forecast - 30 Days FREE Trial $1673M 35,2x 3,6x
CCBG Unlock Forecast - 30 Days FREE Trial $742M 12,8x 1,4x
CCFN Unlock Forecast - 30 Days FREE Trial $175M 8,6x 1,0x
CCNE Unlock Forecast - 30 Days FREE Trial $545M 10,0x 0,9x
CCNEP Unlock Forecast - 30 Days FREE Trial $523M 9,6x 0,8x
CFB Unlock Forecast - 30 Days FREE Trial $0M 12,2x 0,0x
CFFI Unlock Forecast - 30 Days FREE Trial $231M 9,5x 1,0x
CFG Unlock Forecast - 30 Days FREE Trial $22762M 14,3x 0,9x
CFG-PE Unlock Forecast - 30 Days FREE Trial $8985M 5,6x 0,4x
CFG-PH Unlock Forecast - 30 Days FREE Trial $11779M 7,4x 0,5x
CHMG Unlock Forecast - 30 Days FREE Trial $251M 22,4x 1,1x
CIVB Unlock Forecast - 30 Days FREE Trial $0M 10,8x 0,0x
CNOB Unlock Forecast - 30 Days FREE Trial $1252M 33,4x 0,8x
CNOBP Unlock Forecast - 30 Days FREE Trial $1181M 31,5x 0,8x
COFS Unlock Forecast - 30 Days FREE Trial $462M 32,7x 1,1x
COLB Unlock Forecast - 30 Days FREE Trial $5512M 10,4x 1,0x
COSO Unlock Forecast - 30 Days FREE Trial $238M x 1,1x
CPF Unlock Forecast - 30 Days FREE Trial $839M 13,8x 1,5x
CSBB Unlock Forecast - 30 Days FREE Trial $120M 9,4x 1,0x
CTBI Unlock Forecast - 30 Days FREE Trial $1040M 11,4x 1,3x
CUBB Unlock Forecast - 30 Days FREE Trial $693M 4,7x 0,4x
CUBI Unlock Forecast - 30 Days FREE Trial $2212M 15,0x 1,2x
CUBI-PF Unlock Forecast - 30 Days FREE Trial $815M 5,5x 0,4x
CVBF Unlock Forecast - 30 Days FREE Trial $2817M 13,8x 1,3x
CWBC Unlock Forecast - 30 Days FREE Trial $406M 15,4x 1,1x
CZFS Unlock Forecast - 30 Days FREE Trial $295M 9,3x 0,9x
CZNC Unlock Forecast - 30 Days FREE Trial $313M 11,6x 1,1x
EBMT Unlock Forecast - 30 Days FREE Trial $140M 11,1x 0,8x
EBTC Unlock Forecast - 30 Days FREE Trial $496M 14,6x 1,3x
EFSC Unlock Forecast - 30 Days FREE Trial $2287M 11,4x 1,2x
EFSCP Unlock Forecast - 30 Days FREE Trial $771M 3,8x 0,4x
EFSI Unlock Forecast - 30 Days FREE Trial $201M 25,4x 1,1x
EGBN Unlock Forecast - 30 Days FREE Trial $602M -22,5x 0,5x
EMYB Unlock Forecast - 30 Days FREE Trial $133M 11,4x 1,2x
EQBK Unlock Forecast - 30 Days FREE Trial $743M 11,1x 1,2x
EWBC Unlock Forecast - 30 Days FREE Trial $15017M 12,6x 1,8x
FBIZ Unlock Forecast - 30 Days FREE Trial $433M 9,1x 1,3x
FBK Unlock Forecast - 30 Days FREE Trial $2460M 27,2x 1,5x
FBNC Unlock Forecast - 30 Days FREE Trial $2287M 23,5x 1,5x
FBP Unlock Forecast - 30 Days FREE Trial $3565M 11,6x 1,9x
FCBC Unlock Forecast - 30 Days FREE Trial $686M 13,7x 1,4x
FCCO Unlock Forecast - 30 Days FREE Trial $215M 12,4x 1,4x
FCNCA Unlock Forecast - 30 Days FREE Trial $26095M 10,9x 1,2x
FCNCB Unlock Forecast - 30 Days FREE Trial $22320M 9,3x 1,0x
FCNCO Unlock Forecast - 30 Days FREE Trial $307M 0,1x 0,0x
FCNCP Unlock Forecast - 30 Days FREE Trial $294M 0,1x 0,0x
FFIC Unlock Forecast - 30 Days FREE Trial $457M 19,5x 0,7x
FFIN Unlock Forecast - 30 Days FREE Trial $5169M 21,0x 3,0x
FFNW Unlock Forecast - 30 Days FREE Trial $208M 81,8x 1,3x
FFWM Unlock Forecast - 30 Days FREE Trial $494M -23,9x 0,5x
FHB Unlock Forecast - 30 Days FREE Trial $3222M 13,1x 1,2x
FIBK Unlock Forecast - 30 Days FREE Trial $3369M 14,7x 1,0x
FINW Unlock Forecast - 30 Days FREE Trial $261M 19,3x 1,4x
FITB Unlock Forecast - 30 Days FREE Trial $30721M 13,2x 1,5x
FITBI Unlock Forecast - 30 Days FREE Trial $17409M 7,5x 0,8x
FITBO Unlock Forecast - 30 Days FREE Trial $13960M 6,0x 0,7x
FITBP Unlock Forecast - 30 Days FREE Trial $16748M 7,2x 0,8x
FKYS Unlock Forecast - 30 Days FREE Trial $107M 13,8x 1,0x
FMBH Unlock Forecast - 30 Days FREE Trial $954M 11,3x 1,1x
FMBM Unlock Forecast - 30 Days FREE Trial $87M 10,3x 0,9x
FMNB Unlock Forecast - 30 Days FREE Trial $567M 11,2x 1,3x
FRAF Unlock Forecast - 30 Days FREE Trial $211M 14,5x 1,3x
FRST Unlock Forecast - 30 Days FREE Trial $294M -22,0x 0,8x
FSBC Unlock Forecast - 30 Days FREE Trial $696M 13,4x 1,7x
FUSB Unlock Forecast - 30 Days FREE Trial $76M 9,8x 0,7x
FVCB Unlock Forecast - 30 Days FREE Trial $227M 12,0x 0,9x
FXNC Unlock Forecast - 30 Days FREE Trial $212M 26,6x 1,2x
GABC Unlock Forecast - 30 Days FREE Trial $1535M 17,8x 1,4x
GBCI Unlock Forecast - 30 Days FREE Trial $5756M 26,1x 1,6x
GBFH Unlock Forecast - 30 Days FREE Trial $582M x 3,8x
GLBZ Unlock Forecast - 30 Days FREE Trial $16M 28,2x 0,8x
GNRV Unlock Forecast - 30 Days FREE Trial $7M x 0,7x
GSBC Unlock Forecast - 30 Days FREE Trial $733M 10,7x 1,2x
HBIA Unlock Forecast - 30 Days FREE Trial $749M 13,3x 1,5x
HBNC Unlock Forecast - 30 Days FREE Trial $720M 13,9x 0,9x
HBT Unlock Forecast - 30 Days FREE Trial $812M 10,6x 1,4x
HMST Unlock Forecast - 30 Days FREE Trial $262M -13,1x 0,7x
HNVR Unlock Forecast - 30 Days FREE Trial $166M 14,6x 0,8x
HOMB Unlock Forecast - 30 Days FREE Trial $5852M 15,8x 1,4x
HONE Unlock Forecast - 30 Days FREE Trial $559M 21,2x 1,0x
HTBK Unlock Forecast - 30 Days FREE Trial $635M 16,2x 0,9x
HTH Unlock Forecast - 30 Days FREE Trial $2259M 15,8x 1,0x
HTLF Unlock Forecast - 30 Days FREE Trial $0M 33,6x 0,0x
HTLFP Unlock Forecast - 30 Days FREE Trial $0M 12,6x 0,0x
HWC Unlock Forecast - 30 Days FREE Trial $5445M 13,1x 1,3x
HWCPZ Unlock Forecast - 30 Days FREE Trial $2067M 5,5x 0,5x
IBCP Unlock Forecast - 30 Days FREE Trial $1380M 21,3x 2,9x
IBOC Unlock Forecast - 30 Days FREE Trial $4412M 10,7x 1,5x
IBTX Unlock Forecast - 30 Days FREE Trial $2514M -8,0x 1,3x
INBK Unlock Forecast - 30 Days FREE Trial $215M 13,9x 0,6x
INBKZ Unlock Forecast - 30 Days FREE Trial $218M 14,1x 0,6x
INDB Unlock Forecast - 30 Days FREE Trial $2955M 15,7x 1,0x
ISBA Unlock Forecast - 30 Days FREE Trial $239M 14,7x 1,1x
ISTR Unlock Forecast - 30 Days FREE Trial $230M 10,3x 0,9x
JMSB Unlock Forecast - 30 Days FREE Trial $288M 15,2x 1,1x
LKFN Unlock Forecast - 30 Days FREE Trial $1711M 18,1x 2,4x
LNKB Unlock Forecast - 30 Days FREE Trial $274M 71,1x 1,0x
LOB Unlock Forecast - 30 Days FREE Trial $1703M 30,4x 1,6x
MBCN Unlock Forecast - 30 Days FREE Trial $246M 13,5x 1,1x
MBIN Unlock Forecast - 30 Days FREE Trial $1439M 5,7x 0,7x
MBINL Unlock Forecast - 30 Days FREE Trial $1070M 4,2x 0,5x
MBINM Unlock Forecast - 30 Days FREE Trial $1166M 4,6x 0,5x
MBINN Unlock Forecast - 30 Days FREE Trial $945M 3,7x 0,4x
MBINO Unlock Forecast - 30 Days FREE Trial $1144M 4,0x 0,6x
MBWM Unlock Forecast - 30 Days FREE Trial $786M 9,7x 1,3x
MCB Unlock Forecast - 30 Days FREE Trial $856M 12,5x 1,2x
MCBS Unlock Forecast - 30 Days FREE Trial $760M 11,5x 1,7x
MNSB Unlock Forecast - 30 Days FREE Trial $170M 11,1x 0,8x
MNSBP Unlock Forecast - 30 Days FREE Trial $183M 13,3x 0,9x
MOFG Unlock Forecast - 30 Days FREE Trial $622M -84,8x 1,1x
MPB Unlock Forecast - 30 Days FREE Trial $693M 15,7x 0,9x
MSBI Unlock Forecast - 30 Days FREE Trial $394M 7,4x 0,5x
MSBIP Unlock Forecast - 30 Days FREE Trial $514M 9,7x 0,6x
MTB Unlock Forecast - 30 Days FREE Trial $32205M 11,9x 1,1x
MTB-PH Unlock Forecast - 30 Days FREE Trial $4029M 1,5x 0,1x
MTB-PJ Unlock Forecast - 30 Days FREE Trial $4375M 1,6x 0,2x
MVBF Unlock Forecast - 30 Days FREE Trial $316M 18,5x 1,1x
MYFW Unlock Forecast - 30 Days FREE Trial $226M 19,6x 0,9x
NPB Unlock Forecast - 30 Days FREE Trial $641M x 1,1x
NTRS Unlock Forecast - 30 Days FREE Trial $24744M 14,3x 1,9x
NTRSO Unlock Forecast - 30 Days FREE Trial $4014M 2,3x 0,3x
NWFL Unlock Forecast - 30 Days FREE Trial $247M 77,9x 1,1x
NWPP Unlock Forecast - 30 Days FREE Trial $75M 8,2x 1,0x
OBK Unlock Forecast - 30 Days FREE Trial $1179M 16,9x 1,0x
OBT Unlock Forecast - 30 Days FREE Trial $357M 12,1x 1,4x
OFG Unlock Forecast - 30 Days FREE Trial $1993M 10,2x 1,5x
OPBK Unlock Forecast - 30 Days FREE Trial $212M 9,5x 1,0x
ORRF Unlock Forecast - 30 Days FREE Trial $683M 15,8x 1,3x
OSBC Unlock Forecast - 30 Days FREE Trial $837M 10,0x 1,2x
OVBC Unlock Forecast - 30 Days FREE Trial $0M 7,7x 0,0x
OVLY Unlock Forecast - 30 Days FREE Trial $245M 10,1x 1,3x
PB Unlock Forecast - 30 Days FREE Trial $6414M 12,3x 0,8x
PBHC Unlock Forecast - 30 Days FREE Trial $84M 12,4x 0,7x
PCB Unlock Forecast - 30 Days FREE Trial $313M 9,9x 0,8x
PEBK Unlock Forecast - 30 Days FREE Trial $173M 10,2x 1,2x
PEBO Unlock Forecast - 30 Days FREE Trial $1074M 10,3x 0,9x
PFBX Unlock Forecast - 30 Days FREE Trial $92M 4,7x 1,0x
PFC Unlock Forecast - 30 Days FREE Trial $1038M 13,2x 1,0x
PKBK Unlock Forecast - 30 Days FREE Trial $270M 8,7x 0,9x
PMHG Unlock Forecast - 30 Days FREE Trial $171M 21,0x 1,9x
PPBI Unlock Forecast - 30 Days FREE Trial $2376M 17,2x 0,8x
PWOD Unlock Forecast - 30 Days FREE Trial $244M 14,7x 1,5x
QCRH Unlock Forecast - 30 Days FREE Trial $1324M 11,7x 1,3x
QNBC Unlock Forecast - 30 Days FREE Trial $132M 10,3x 1,2x
RBB Unlock Forecast - 30 Days FREE Trial $354M 15,4x 0,7x
RBCAA Unlock Forecast - 30 Days FREE Trial $1511M 12,2x 1,4x
RMBI Unlock Forecast - 30 Days FREE Trial $153M 16,1x 1,2x
RNST Unlock Forecast - 30 Days FREE Trial $3672M 23,0x 1,0x
RRBI Unlock Forecast - 30 Days FREE Trial $427M 13,0x 1,3x
RVRF Unlock Forecast - 30 Days FREE Trial $272M 7,1x 1,1x
SBCF Unlock Forecast - 30 Days FREE Trial $2645M 19,1x 1,2x
SBFG Unlock Forecast - 30 Days FREE Trial $8M 10,8x 0,1x
SBSI Unlock Forecast - 30 Days FREE Trial $926M 10,8x 1,2x
SFBS Unlock Forecast - 30 Days FREE Trial $4605M 18,4x 2,7x
SFDL Unlock Forecast - 30 Days FREE Trial $98M 8,4x 0,5x
SLBK Unlock Forecast - 30 Days FREE Trial $101M 9,3x 1,0x
SPFI Unlock Forecast - 30 Days FREE Trial $687M 12,6x 1,5x
SRCE Unlock Forecast - 30 Days FREE Trial $1644M 11,6x 1,4x
SSB Unlock Forecast - 30 Days FREE Trial $10326M 17,5x 1,2x
SSBK Unlock Forecast - 30 Days FREE Trial $361M 10,6x 1,2x
STBA Unlock Forecast - 30 Days FREE Trial $1499M 12,4x 1,1x
STT Unlock Forecast - 30 Days FREE Trial $32300M 11,3x 1,2x
STT-PG Unlock Forecast - 30 Days FREE Trial $6765M 2,4x 0,3x
SYBT Unlock Forecast - 30 Days FREE Trial $2294M 17,9x 2,3x
TCBI Unlock Forecast - 30 Days FREE Trial $4048M 30,2x 1,2x
TCBIO Unlock Forecast - 30 Days FREE Trial $954M 7,1x 0,3x
TCBK Unlock Forecast - 30 Days FREE Trial $1497M 13,4x 1,2x
TECTP Unlock Forecast - 30 Days FREE Trial $74M 4,5x 0,6x
TFIN Unlock Forecast - 30 Days FREE Trial $1466M 107,7x 1,6x
TFINP Unlock Forecast - 30 Days FREE Trial $522M 38,3x 0,6x
THFF Unlock Forecast - 30 Days FREE Trial $664M 12,1x 1,2x
TMP Unlock Forecast - 30 Days FREE Trial $0M 47,6x 0,0x
TRST Unlock Forecast - 30 Days FREE Trial $752M 14,1x 1,1x
UBCP Unlock Forecast - 30 Days FREE Trial $82M 9,3x 1,4x
UBSI Unlock Forecast - 30 Days FREE Trial $5389M 13,7x 1,0x
UCB Unlock Forecast - 30 Days FREE Trial $3951M 14,5x 1,1x
UCB-PI Unlock Forecast - 30 Days FREE Trial $3033M 11,1x 0,8x
UNB Unlock Forecast - 30 Days FREE Trial $0M 16,5x 0,0x
UNTY Unlock Forecast - 30 Days FREE Trial $534M 10,6x 1,7x
USCB Unlock Forecast - 30 Days FREE Trial $0M -3,5x 0,0x
UVSP Unlock Forecast - 30 Days FREE Trial $909M 11,4x 1,0x
UWHR Unlock Forecast - 30 Days FREE Trial $84M 8,3x 1,5x
VBFC Unlock Forecast - 30 Days FREE Trial $120M 56,1x 1,6x
VBTX Unlock Forecast - 30 Days FREE Trial $3748M 32,4x 2,3x
WAL Unlock Forecast - 30 Days FREE Trial $10131M 12,0x 1,4x
WAL-PA Unlock Forecast - 30 Days FREE Trial $2587M 3,1x 0,4x
WASH Unlock Forecast - 30 Days FREE Trial $581M 13,8x 1,1x
WTBA Unlock Forecast - 30 Days FREE Trial $345M 11,9x 1,4x
WTFC Unlock Forecast - 30 Days FREE Trial $9280M 12,5x 1,3x
WTFCM Unlock Forecast - 30 Days FREE Trial $1807M 2,6x 0,3x
WTFCN Unlock Forecast - 30 Days FREE Trial $1811M 2,5x 0,3x
WTFCP Unlock Forecast - 30 Days FREE Trial $1814M 2,6x 0,3x

Preguntas frecuentes - STATE STREET CORP Previsión de existencias

¿Hasta qué punto son precisas las predicciones bursátiles de STATE STREET CORP?

Our AI model demonstrates 61% historical accuracy for STT predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

¿Qué factores influyen en las previsiones STATE STREET CORP del precio de las acciones?

Nuestro análisis tiene en cuenta las métricas financieras de STATE STREET CORP, las tendencias del sector Finance, el sentimiento del mercado, los indicadores técnicos, los datos de beneficios y los factores macroeconómicos que afectan al rendimiento de las acciones.

¿Es STATE STREET CORP una buena inversión en 2025?

Según nuestro análisis de IA, STATE STREET CORP muestra potencial para diversos escenarios de mercado. Considere su tolerancia al riesgo, el plazo de inversión y la diversificación de la cartera antes de tomar decisiones de inversión.

¿Con qué frecuencia se actualizan las previsiones STATE STREET CORP?

Las previsiones bursátiles de STATE STREET CORP se actualizan a diario utilizando datos de mercado en tiempo real, lo que garantiza que reciba las predicciones y perspectivas de inversión más actuales basadas en IA.

¿Desea un análisis STATE STREET CORP más avanzado?

Desbloquee las funciones premium, incluidos los objetivos de precios detallados, las evaluaciones de riesgo, la optimización de la cartera y las alertas en tiempo real para las acciones STATE STREET CORP.

🎯 Análisis Premium 📊 Más acciones

Mi cartera

Panel de inversiones

Cargando su cartera...